Home  »  Trending   »  Precision BioSciences Inc. (DTIL) vs. Its Peers: A...

Precision BioSciences Inc. (DTIL) vs. Its Peers: A Comparison

Additionally, the 36-month beta value for DTIL is 1.39. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”

The average price predicted by analysts for DTIL is $6.67, which is $5.56 above the current price. The public float for DTIL is 91.97M and currently, short sellers hold a 0.78% ratio of that float. The average trading volume of DTIL on May 26, 2023 was 558.17K shares.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


DTIL) stock’s latest price update

Precision BioSciences Inc. (NASDAQ: DTIL)’s stock price has gone decline by -10.17 in comparison to its previous close of 0.82, however, the company has experienced a 0.32% increase in its stock price over the last five trading days.

DTIL’s Market Performance

Precision BioSciences Inc. (DTIL) has experienced a 0.32% rise in stock performance for the past week, with a -9.71% drop in the past month, and a -33.42% drop in the past quarter. The volatility ratio for the week is 11.38%, and the volatility levels for the past 30 days are at 7.94% for DTIL. The simple moving average for the past 20 days is -8.86% for DTIL’s stock, with a -39.44% simple moving average for the past 200 days.

DTIL Trading at -9.69% from the 50-Day Moving Average

After a stumble in the market that brought DTIL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.86% of loss for the given period.

Volatility was left at 7.94%, however, over the last 30 days, the volatility rate increased by 11.38%, as shares sank -10.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.57% lower at present.

During the last 5 trading sessions, DTIL rose by +0.32%, which changed the moving average for the period of 200-days by -52.13% in comparison to the 20-day moving average, which settled at $0.7992. In addition, Precision BioSciences Inc. saw -38.45% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at DTIL starting from List Alan, who sale 7,771 shares at the price of $0.79 back on Apr 27. After this action, List Alan now owns 56,496 shares of Precision BioSciences Inc., valued at $6,139 using the latest closing price.

Amoroso Michael, the President and CEO of Precision BioSciences Inc., sale 46,999 shares at $0.82 during a trade that took place back on Mar 22, which means that Amoroso Michael is holding 68,738 shares at $38,539 based on the most recent closing price.

Stock Fundamentals for DTIL

Current profitability levels for the company are sitting at:

  • -399.90 for the present operating margin
  • +64.12 for the gross margin

The net margin for Precision BioSciences Inc. stands at -444.80. The total capital return value is set at -106.91, while invested capital returns managed to touch -121.42. Equity return is now at value -150.70, with -42.90 for asset returns.

Based on Precision BioSciences Inc. (DTIL), the company’s capital structure generated 44.74 points at debt to equity in total, while total debt to capital is 30.91. Total debt to assets is 11.35, with long-term debt to equity ratio resting at 41.37. Finally, the long-term debt to capital ratio is 28.58.

When we switch over and look at the enterprise to sales, we see a ratio of -2.28, with the company’s debt to enterprise value settled at -0.47. The receivables turnover for the company is 41.55 and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.34.


In conclusion, Precision BioSciences Inc. (DTIL) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.